首页> 美国卫生研究院文献>other >μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain
【2h】

μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain

机译:阿片类药物受体对原发性P物质释放的抑制作用在神经性疼痛中消失但在炎症性疼痛中消失

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Opiate analgesia in the spinal cord is impaired during neuropathic pain. We hypothesized that this is caused by a decrease in μ-opioid receptor inhibition of neurotransmitter release from primary afferents. To investigate this possibility, we measured substance P release in the spinal dorsal horn as neurokinin 1 receptor (NK1R) internalization in rats with chronic constriction injury (CCI) of the sciatic nerve. Noxious stimulation of the paw with CCI produced inconsistent NK1R internalization, suggesting that transmission of nociceptive signals by the injured nerve was variably impaired after CCI. This idea was supported by the fact that CCI produced only small changes in the ability of exogenous substance P to induce NK1R internalization or in the release of substance P evoked centrally from site of nerve injury.In subsequent experiments, NK1R internalization was induced in spinal cord slices by stimulating the dorsal root ipsilateral to CCI. We observed a complete loss of the inhibition of substance P release by the μ-opioid receptor agonist [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin (DAMGO) in CCI rats but not in sham-operated rats. In contrast, DAMGO still inhibited substance P release after inflammation of the hind paw with complete Freund’s adjuvant and in naïve rats. This loss of inhibition was not due to μ-opioid receptor downregulation in primary afferents, because their colocalization with substance P was unchanged, both in dorsal root ganglion neurons and primary afferent fibers in the dorsal horn. In conclusion, nerve injury eliminates the inhibition of substance P release by μ-opioid receptors, probably by hindering their signaling mechanisms.
机译:在神经性疼痛中,脊髓中的阿片类镇痛作用减弱。我们假设这是由减少μ阿片受体抑制从初级传入神经释放神经递质引起的。为了研究这种可能性,我们测量了坐骨神经慢性压迫性损伤(CCI)大鼠中脊髓背角中P物质的释放,作为神经激肽1受体(NK1R)内在化。 CCI对脚爪的有害刺激产生不一致的NK1R内部化,这表明CCI后受损神经的伤害性信号传递受到不同程度的损害。 CCI在外源性物质P诱导NK1R内在化或从神经损伤部位集中诱发的P物质释放方面仅产生了微小变化,这一事实得到了这一观点的支持。在随后的实验中,脊髓中诱导了NK1R内化通过刺激CCI的同侧背根切片。我们观察到μ阿片受体激动剂[D-Ala 2 ,NMe-Phe 4 ,Gly-ol 对P物质释放的抑制作用完全消失。 5 ]-脑啡肽(DAMGO)在CCI大鼠中却没有在假手术大鼠中。相比之下,DAMGO在完全弗氏佐剂和幼稚大鼠的后爪发炎后仍能抑制P物质的释放。这种抑制作用的丧失不是由于初级传入神经中的μ阿片受体下调,因为它们在背根神经节神经元和背角初级传入纤维中与P物质的共定位均未改变。总之,神经损伤消除了μ阿片受体对P物质释放的抑制作用,这可能是因为它们阻碍了其信号传导机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号